Altogether, we found that the nomograms incorporating the expression levels of WWP1 and SHP2 achieve a more accurate prediction of OS and DFS in CRC patients, offering valuable support for clinical decision-making and trial design. The gene discussed is PTPN11; the disease is colorectal carcinoma.